Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Ongoing Initiated Feb 5, 2026 (8 months ago)

ketamine HCl

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility

Cause type: Sterility / contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections. All sterility / contamination recalls.

What was recalled

ketamine HCl, 1,000 mg, 1,000 mg per 100 mL (10 mg per mL) in Sodium Chloride Injection, Fagron Sterile Services, 20 Dan Road, Canton, MA 02021, NDC 71506-050-56

Affected NDC 71506-0050-56

Compare with the code on your package — it is the most precise check available.

Drug: Ketamine

Recalling firm
Fresenius Kabi Compounding, LLC
NDC code
71506-050-56
Origin
MA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0334-2026 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall.

Other Ketamine recalls

See all

Other recalls by Fresenius Kabi Compounding, LLC

All 2026 recalls